What does Pospiech Anesthésiologie do?

Pospiech Anesthésiologie is a specialist medical practice in Beauvechain. Private Limited, started on 8 February 2019, 1 establishment.

What is the address of Pospiech Anesthésiologie?

The registered office of Pospiech Anesthésiologie is located at Rue de la Comtesse Alpayde 39, 1320 Beauvechain.

Is Pospiech Anesthésiologie still active?

Yes. According to the CBE (17 September 2026) Pospiech Anesthésiologie is active, legal situation “Normale toestand”, started on 8 February 2019.

Is Pospiech Anesthésiologie registered on Peppol?

Yes, Pospiech Anesthésiologie is registered on the Peppol network with ID 0208:0719986161.

What is the enterprise number of Pospiech Anesthésiologie?

The enterprise number of Pospiech Anesthésiologie is BE0719986161.

When was Pospiech Anesthésiologie founded?

Pospiech Anesthésiologie was founded on 8 February 2019.

Who are the directors of Pospiech Anesthésiologie?

According to the 2025 annual accounts, the directors of Pospiech Anesthésiologie are: Audrey Pospiech.

Is Pospiech Anesthésiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 February 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pospiech Anesthésiologie make in 2025?

Pospiech Anesthésiologie posted a profit after taxes of € 193,697 in financial year 2025.

What is the revenue of Pospiech Anesthésiologie?

As a small company, Pospiech Anesthésiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 262,995.

Pospiech Anesthésiologie (Private Limited) - Beauvechain

Dossier Pospiech Anesthésiologie, printed on 17 September 2026 from databakkes.be/en/0719986161/pospiech-anesthesiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pospiech Anesthésiologie from Beauvechain, company number BE0719986161, closed financial year 2025 with a result of € 193,697 after tax. For that financial year Pospiech Anesthésiologie recorded a gross margin of € 262,995 and equity of € 8,600. Compared with financial year 2024, the result moved from € 228,044 to € 193,697. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.

What it is worth Healthy

€ 8,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 193,697

▼ 15% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 119,514

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 193,697 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,531

▲ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 22,882

▲ 13% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 111

▼ 91% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,500

▼ 48% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 220,661 Gross margin 2022: € 220,661 First fiscal year in the series	€ 220,223 Gross margin 2023: € 220,223 Unchanged (€ 220,661) Unfavourable step	€ 302,189 Gross margin 2024: € 302,189 ▲ 37% vs 2023 (€ 220,223) Favourable step	€ 262,995 Gross margin 2025: € 262,995 ▼ 13% vs 2024 (€ 302,189) Unfavourable step	▼ 13%
Profit after taxes	€ 154,551 Profit after taxes 2022: € 154,551 First fiscal year in the series	€ 159,498 Profit after taxes 2023: € 159,498 ▲ 3% vs 2022 (€ 154,551) Favourable step	€ 228,044 Profit after taxes 2024: € 228,044 ▲ 43% vs 2023 (€ 159,498) Favourable step	€ 193,697 Profit after taxes 2025: € 193,697 ▼ 15% vs 2024 (€ 228,044) Unfavourable step	▼ 15%
Equity	€ 18,600 Equity 2022: € 18,600 First fiscal year in the series	€ 18,600 Equity 2023: € 18,600 Unchanged (€ 18,600) Unchanged	€ 8,600 Equity 2024: € 8,600 ▼ 54% vs 2023 (€ 18,600) Unfavourable step	€ 8,600 Equity 2025: € 8,600 Unchanged (€ 8,600) Unchanged
Total debts	€ 288,783 Total debts 2022: € 288,783 First fiscal year in the series	€ 210,140 Total debts 2023: € 210,140 ▼ 27% vs 2022 (€ 288,783) Favourable step	€ 259,238 Total debts 2024: € 259,238 ▲ 23% vs 2023 (€ 210,140) Unfavourable step	€ 225,312 Total debts 2025: € 225,312 ▼ 13% vs 2024 (€ 259,238) Favourable step	▼ 13%
Cash	€ 166,563 Cash 2022: € 166,563 First fiscal year in the series	€ 107,744 Cash 2023: € 107,744 ▼ 35% vs 2022 (€ 166,563) Unfavourable step	€ 147,997 Cash 2024: € 147,997 ▲ 37% vs 2023 (€ 107,744) Favourable step	€ 119,514 Cash 2025: € 119,514 ▼ 19% vs 2024 (€ 147,997) Unfavourable step	▼ 19%
Dividend	€ 490,004 Dividend 2022: € 490,004 First fiscal year in the series	€ 159,498 Dividend 2023: € 159,498 ▼ 67% vs 2022 (€ 490,004) Unchanged	€ 228,044 Dividend 2024: € 228,044 ▲ 43% vs 2023 (€ 159,498) Unchanged	€ 193,697 Dividend 2025: € 193,697 ▼ 15% vs 2024 (€ 228,044) Unchanged	▼ 15%
Bank debt	€ 19,311 Bank debt 2022: € 19,311 First fiscal year in the series	€ 18,542 Bank debt 2023: € 18,542 ▼ 4% vs 2022 (€ 19,311) Favourable step	€ 20,247 Bank debt 2024: € 20,247 ▲ 9% vs 2023 (€ 18,542) Unfavourable step	€ 22,882 Bank debt 2025: € 22,882 ▲ 13% vs 2024 (€ 20,247) Unfavourable step	▲ 13%
Balance sheet total	€ 307,383 Balance sheet total 2022: € 307,383 First fiscal year in the series	€ 228,740 Balance sheet total 2023: € 228,740 ▼ 26% vs 2022 (€ 307,383) Unchanged	€ 267,838 Balance sheet total 2024: € 267,838 ▲ 17% vs 2023 (€ 228,740) Unchanged	€ 233,912 Balance sheet total 2025: € 233,912 ▼ 13% vs 2024 (€ 267,838) Unchanged	▼ 13%

Key figures of Pospiech Anesthésiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pospiech Anesthésiologie?

What happened at Pospiech Anesthésiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 28, 2026 New annual accounts for financial year 2025: profit of € 193,697 (▼ 15% vs 2024). Source: NBB ↗
Feb 8, 2019 New establishment in Beauvechain. KBO
Feb 8, 2019 Start of the company according to the CBE. KBO

In short

From € 154,551 profit in 2022 to € 193,697 profit in 2025.

Paid € 233,943 in corporate taxes since 2022.

Best year ever: 2024, with € 228,044 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Pospiech Anesthésiologie? We notify you, reason included.

Follow Pospiech Anesthésiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Audrey Pospiech

Pospiech Anesthésiologie

Behind Pospiech Anesthésiologie is Audrey Pospiech.

See the full network in the app

Directors

According to the 2025 annual accounts

Audrey Pospiech

Administratrice

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Comtesse Alpayde 39

1320 Beauvechain

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0719.986.161
VAT number: BE 0719.986.161
Registered office: Rue de la Comtesse Alpayde 39, 1320 Beauvechain
Names & denominations: Pospiech Anesthésiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 February 2019
Peppol: Active · Active since 24 Jan 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗